
CAS: 3367-88-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 3-(pyridin-2-ylmethylidene)-1,3-dihydro-2h-indol-2-one REF: IN-DA01GA56CAS: 3367-88-2 | 97% | To inquire | Mon 14 Apr 25 |
![]() | (E/Z)-GSK-3β inhibitor 1 REF: 54-BUP07613CAS: 3367-88-2 | 99.8% | 342.00 €~957.00 € | Tue 15 Apr 25 |
![]() | (E/Z)-GSK-3β inhibitor 1 REF: TM-T9178CAS: 3367-88-2 | 98.60% | 38.00 €~1,606.00 € | Mon 21 Apr 25 |
![]() | 3-[(2-Pyridinyl)methylene]indolin-2-one REF: 3D-DAA36788CAS: 3367-88-2 | Min. 95% | - - - | Discontinued product |

3-(pyridin-2-ylmethylidene)-1,3-dihydro-2h-indol-2-one
CAS:3367-88-2
Formula:
C14H10N2O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
222.242
Ref: IN-DA01GA56
5mg | 180.00 € | ||
10mg | 214.00 € | ||
25mg | 574.00 € | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 14 Apr 2025

Ref: 54-BUP07613
25mg | 342.00 € | ||
50mg | 500.00 € | ||
100mg | 718.00 € | ||
200mg | 957.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

(E/Z)-GSK-3β inhibitor 1
CAS:3367-88-2
(E/Z)-GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic …
Formula:
C14H10N2O
Purity:
98.60%
Color and Shape:
Solid
Molecular weight:
222.24
- Inhibitors
- Stem Cell and Derivatives
- Stem Cells
- PI3K/Akt/mTOR Signaling
- See more categories
- gsk-3
Ref: TM-T9178
1mg | 38.00 € | ||
5mg | 85.00 € | ||
10mg | 126.00 € | ||
25mg | 225.00 € | ||
50mg | 335.00 € | ||
100mg | 480.00 € | ||
200mg | 652.00 € | ||
1mL*10mM (DMSO) | 94.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

3-[(2-Pyridinyl)methylene]indolin-2-one
CAS:3367-88-2
Please enquire for more information about 3-[(2-Pyridinyl)methylene]indolin-2-one including the price, delivery time and more detailed …
Formula:
C14H10N2O
Purity:
Min. 95%
Molecular weight:
222.24 g/mol
Ref: 3D-DAA36788
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |